Exhibitors & Sponsors
Color’s mission is to democratize access to genetic information. For $249, Color provides a clinical-grade physician ordered test. The Color Test analyzes 30-genes to help women and men learn their risk for the most common hereditary cancers: breast, ovarian, colorectal, pancreatic and other cancers. Complimentary genetic testing included.
Founded more than 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, CA.
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging health care issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Pfizer Oncology is committed to the discovery, investigation, and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline of biologics and small molecules, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers. By working collaboratively with academic institutions, individual researchers, cooperative research groups, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines, to deliver the right drug for each patient at the right time.
Sharsheret supports young Jewish women and families facing breast cancer at every stage―before, during, and after diagnosis. We provide educational resources, offer support to those at high risk of developing breast or ovarian cancer, and create programs for women and families to improve their quality of life.
Taiho Oncology has built a world-class clinical development organization that works urgently to develop innovative cancer treatments. Taiho is focused on bringing novel technology to cornerstone chemotherapies for a wide range of tumor types, including colorectal cancer and a variety of solid tumors.
Our mission is unchanged as we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation, and passion for improving the lives of patients. This singular focus drives our aspiration to discover, develop, and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, we are finding innovative ways to improve the treatment of cancer.
We’ve built a portfolio of paradigm-changing therapies and a leading oncology pipeline. While we’ve made great strides in our fight against cancer, we are determined to do more—to work harder and to reach higher. We will do this with the same passion, agility, and entrepreneurial spirit that has sustained the heart of our culture and has made us the leader in oncology that we are today.
We know that our mission is not a quick or easy one, but we are up to the task: we aspire to cure cancer.